Leveraging expertise in production optimization, regulatory compliance, clinical excellence, and fostering a positive organizational culture
146 Pinel RiosJ.Madrid NavarroC
Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials
Please reschedule your appointment if you have a wound or an active infection in the treatment area
Cancer Res 57 : 52325237 Schneider, E, Horton, JK, Yang, CH, Nakagawa, M & Cowan, KH (1994) Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance